OptimizeRx to Acquire Caregility Corp.

Ticker: OPRX · Form: 8-K · Filed: Apr 18, 2025 · CIK: 1448431

Optimizerx CORP 8-K Filing Summary
FieldDetail
CompanyOptimizerx CORP (OPRX)
Form Type8-K
Filed DateApr 18, 2025
Risk Levelmedium
Sentimentmixed

Sentiment: mixed

Topics: acquisition, m&a, digital-health

TL;DR

OptimizeRx buying Caregility to boost digital health biz, closing Q2 2025.

AI Summary

OptimizeRx Corp announced on April 18, 2025, that it has entered into a definitive agreement to acquire Caregility Corp. The transaction is expected to close in the second quarter of 2025, subject to customary closing conditions. This acquisition aims to expand OptimizeRx's digital health platform and patient engagement capabilities.

Why It Matters

This acquisition signifies OptimizeRx's strategic move to broaden its reach in the digital health market, potentially enhancing its service offerings and market position.

Risk Assessment

Risk Level: medium — The acquisition is subject to customary closing conditions, which introduces a degree of uncertainty regarding its completion.

Key Players & Entities

FAQ

What is the primary purpose of OptimizeRx Corp's announcement?

OptimizeRx Corp announced on April 18, 2025, that it has entered into a definitive agreement to acquire Caregility Corp.

When is the acquisition of Caregility Corp expected to close?

The acquisition is expected to close in the second quarter of 2025.

What are the conditions for the closing of the Caregility Corp acquisition?

The acquisition is subject to customary closing conditions.

What is the strategic goal behind OptimizeRx Corp acquiring Caregility Corp?

The acquisition aims to expand OptimizeRx's digital health platform and patient engagement capabilities.

What is the filing date of this 8-K report?

The filing date of this 8-K report is April 18, 2025.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 18, 2025 regarding OptimizeRx Corp (OPRX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing